RILUZOLE TEVA 50 mg, comprimé pelliculé — plaquette(s) aluminium PVC de 56 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949912469
  • CIP7 4991246
  • CIS 66879143

What the source publishes

Holder
TEVA SANTE
Active ingredients
RILUZOLE
Form
comprimé pelliculé
Package
plaquette(s) aluminium PVC de 56 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale annuelle réservée à certains spécialistes ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2011-10-13
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949912469
{
  "cis": "66879143",
  "cip7": "4991246",
  "form": "comprimé pelliculé",
  "name": "RILUZOLE TEVA 50 mg, comprimé pelliculé — plaquette(s) aluminium PVC de 56 comprimé(s)",
  "cip13": "3400949912469",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "139.35",
  "authorisedOn": "2011-10-13",
  "compositions": [
    {
      "name": "RILUZOLE",
      "nature": "SA",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "59737",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services NEUROLOGIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale annuelle réservée à certains spécialistes ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "138.33",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "RILUZOLE TEVA 50 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) aluminium PVC de 56 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2012-10-26",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "RILUZOLE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services NEUROLOGIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale annuelle réservée à certains spécialistes",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949912469"